Triple
T10292167
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | bortezomib |
E241388
|
entity |
| Predicate | developer |
P73
|
FINISHED |
| Object |
Millennium Pharmaceuticals
Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.
|
E852353
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d381aaafc08190af475ef58dc16aba |
elicitation | completed |
| NER | batch_69d4d2d35f048190a215493acdf1f718 |
ner | completed |
| NED1 | batch_69d6f85dcbac8190a2ac66354010e328 |
ned_source_triple | completed |
| NED2 | batch_69d6fd879ab88190b0a47295f5d7ad4d |
ned_description | completed |
| NEDg | batch_69d6fcaee26c8190a19f7d07a63531f6 |
nedg | completed |
Created at: April 6, 2026, 11:42 a.m.